< Back to search
Filter
1
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: New Haven CT, Orlando FL, Toronto, Nashville TX,
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT05800665

Phase1, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Nashville TN, Scottsdale AZ
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT07567846

Phase1, Phase2, Recruiting
Featured

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Providence RI, The Bronx NY, Montreal, Myrtle Beach SC,
Sponsor: Hoffmann-La Roche

Sex: Male

Age: 18+

Code: NCT07287150

Phase2, Recruiting
Active & Responsive

Understanding of Genetics by Men at Risk for Prostate Cancer

for
Prostate Cancer
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Mayo Clinic

Sex: Male

Age: 40 - 70+

Code: NCT04550845

Recruiting
Active & ResponsiveNew

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

for
Prostate Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: Male

Age: 18+

Code: NCT07226713

Phase2, Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

for
Metastatic Castration-Resistant Prostate Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07698535

Phase2, Recruiting
Active & ResponsiveNew

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

for
Prostate Cancer Screening
Location: Durham NC, Hardeeville SC
Sponsor: Uro-1 Medical

Sex: Male

Age: 18+

Code: NCT06830265

Recruiting
Active & Responsive

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06559059

Recruiting
Active & Responsive

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

for
Prostate Cancer
Location: New York NY
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT06807359

Phase1, Phase2, Recruiting
Active & Responsive

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 0+

Code: NCT06145633

Phase2, Recruiting
Active & Responsive

PET/CT Characterization of Treatment Resistance

for
Prostate Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT05647564

Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting
Active & Responsive

Real World Prostate Cancer Registry

for
Prostate Cancer
Location: Cincinnati OH
Sponsor: Cincinnati Cancer Advisors

Sex: Male

Age: 18+

Code: NCT06355336

Recruiting
Active & Responsive

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

for
Metastatic Prostate Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Male

Age: 18+

Code: NCT05627219

Recruiting
Active & Responsive

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

for
Prostate Cancer
Location: San Francisco CA
Sponsor: Robert Bok, MD, PhD

Sex: Male

Age: 18+

Code: NCT06391034

Phase2, Recruiting
Active & Responsive

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

for
Prostate Cancer
Location: Indianapolis IN, Carmel IN
Sponsor: Indiana University

Sex: Male

Age: 40+

Code: NCT05879913

Recruiting
Active & Responsive

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Columbia MD, Fairfax VA, Margate FL, Plantation FL,
Sponsor: Zenith Epigenetics

Sex: Male

Age: 18+

Code: NCT04986423

Phase2, Recruiting
Active & Responsive

EDRN Prostate MRI Biomarker Study

for
PSA, Prostate Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: Male

Age: 18+

Code: NCT03784924

Recruiting
Active & Responsive

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

for
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Male

Age: 18+

Code: NCT05852041

Early_phase1, Recruiting